XBP vs NIVF

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 09, 2026

XBP

66.7
AI Score
VS
XBP Wins

NIVF

32.4
AI Score

Investment Advisor Scores

XBP

67score
Recommendation
STRONG BUY

NIVF

32score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric XBP NIVF Winner
Forward P/E 0 0.0015 Tie
PEG Ratio 0 0 Tie
Revenue Growth 4.7% -4.7% XBP
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 66.7/100 32.4/100 XBP
Profit Margin 134.9% 24.2% XBP
Beta 1.00 1.00 Tie
AI Recommendation STRONG BUY AVOID NEW MONEY XBP

Relative Price Performance (Last 90 Days)

XBP 1M: -6.5% · 3M: +2.9% NIVF 1M: -5.7% · 3M: -52.7%

Current Technical Phase

XBP

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 52

RSI (14): 52.1 · Price: $3.00

NIVF

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 40

RSI (14): 40.1 · Price: $0.28

Fundamentals Snapshot

Metric XBP NIVF
Market Cap — —
Forward P/E -2.0 0.0
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin 0.2% 0.2%
Operating Margin 0.0% -2.4%
EPS -2.90 -37339.45
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, XBP is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.